Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 351.50%11.44B | 47.33%2.53B | -30.40%1.72B | 71.30%2.47B | -13.38%1.44B | 0.79%1.66B | -5.76%1.65B | 12.63%1.75B | 11.56%1.56B | 21.40%1.4B |
Net profit before non-cash adjustment | -69.09%2.51B | 227.66%8.12B | 14.95%2.48B | 15.09%2.16B | 5.99%1.87B | 8.60%1.77B | -7.85%1.63B | 25.54%1.77B | 22.62%1.41B | -0.66%1.15B |
Total adjustment of non-cash items | 101.87%107.21M | -2,671.71%-5.72B | 67.65%222.37M | 128.41%132.64M | -52.73%58.07M | -33.32%122.86M | 834.31%184.25M | -115.65%-25.09M | 7.52%160.33M | 827.99%149.12M |
-Depreciation and amortization | -8.34%505.29M | -1.85%551.27M | 8.89%561.66M | 34.41%515.81M | 62.85%383.77M | 41.71%235.66M | -5.24%166.3M | 12.98%175.49M | 10.64%155.33M | -5.51%140.4M |
-Reversal of impairment losses recognized in profit and loss | --0 | 759.13%433.07M | --50.41M | --0 | ---- | ---- | ---- | --470M | ---- | ---- |
-Share of associates | ---- | ---- | ---- | -448.96%-5.69M | -63.75%1.63M | 17.91%4.5M | 48.58%3.81M | 342.59%2.57M | 74.70%580K | --332K |
-Disposal profit | -108.81%-145.66M | 1,190.15%1.65B | -476.85%-151.68M | -2,178.60%-26.3M | -113.65%-1.15M | -93.52%8.46M | 121.04%130.45M | ---619.96M | --0 | 84.69%-9.36M |
-Net exchange gains and losses | -156.80%-642K | -103.48%-250K | 169.22%7.19M | -2,589.12%-10.38M | -161.37%-386K | 3,410.53%629K | -102.37%-19K | 178.02%802K | -243.98%-1.03M | 136.42%714K |
-Other non-cash items | 96.99%-251.77M | -3,307.91%-8.36B | 28.05%-245.2M | -4.61%-340.8M | -157.78%-325.79M | -8.67%-126.38M | -115.40%-116.3M | -1,091.79%-53.99M | -68.04%5.44M | 123.76%17.04M |
Changes in working capital | 6,570.41%8.82B | 113.48%132.23M | -638.59%-981.01M | 137.25%182.14M | -117.24%-488.95M | -41.04%-225.08M | -1,416.02%-159.58M | 214.95%12.13M | -110.67%-10.55M | 554.05%98.84M |
-Change in receivables | 3,504.56%8.87B | 126.27%246.05M | -2,018.33%-936.45M | -284.13%-44.21M | 224.21%24.01M | 94.02%-19.33M | -13,031.59%-323.42M | 104.89%2.5M | -154.62%-51.15M | -161.87%-20.09M |
-Change in inventory | -1,794.26%-2.31M | -2,340.00%-122K | -100.54%-5K | -82.13%931K | 306.09%5.21M | -21.07%-2.53M | -110.61%-2.09M | 208.22%19.67M | -586.22%-18.18M | 21.25%-2.65M |
-Change in payables | -152.72%-38.67M | 227.93%73.35M | -160.08%-57.34M | 114.47%95.43M | -279.68%-659.65M | -195.37%-173.74M | 1,427.71%182.18M | -76.04%11.93M | -34.37%49.76M | 929.97%75.83M |
-Changes in other current assets | -113.38%-173.39M | -159.60%-81.26M | 769.41%136.35M | -61.46%15.68M | 623.14%40.7M | 82.34%-7.78M | -411.85%-44.05M | -192.88%-8.61M | 136.97%9.27M | -165.34%-25.06M |
-Changes in other current liabilities | 256.59%165.65M | 14.39%-105.79M | -208.10%-123.57M | 13.42%114.31M | 564.30%100.79M | -178.09%-21.71M | 307.95%27.8M | -5,311.74%-13.37M | -100.35%-247K | 319.87%70.81M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 85.78%-4.2M | -29.54M | 71.11%-13K | 38.36%-45K | 27.00%-73K | |||||
Interest received (cash flow from operating activities) | -90.60%14.09M | 114.09%149.95M | 13.95%70.04M | -35.20%61.46M | 57,387.27%94.85M | -99.78%165K | 58,158.73%73.41M | -85.89%126K | -39.82%893K | -98.29%1.48M |
Tax refund paid | -3,501.62%-2.69B | 88.71%-74.67M | -56.42%-661.32M | 20.07%-422.78M | -0.30%-528.96M | 31.68%-527.39M | -48.88%-771.91M | -16.60%-518.49M | 3.46%-444.67M | -17.47%-460.61M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-1K | -1K |
Operating cash flow | 235.91%8.76B | 131.22%2.61B | -46.41%1.13B | 115.11%2.1B | -13.99%978.55M | 19.33%1.14B | -22.77%953.46M | 10.97%1.23B | 18.87%1.11B | 10.92%935.95M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 39.78%-11.56M | -64.16%-19.2M | 53.82%-11.7M | -87.31%-25.32M | 55.90%-13.52M | -83.68%-30.65M | -214.33%-16.69M | 83.44%-5.31M | 8.11%-32.06M | -65.10%-34.89M |
Net intangibles purchase and sale | -30.15%-409.23M | -0.84%-314.43M | 46.74%-311.81M | 3.88%-585.44M | -25.90%-609.05M | -43.32%-483.77M | -37.66%-337.55M | -122.79%-245.2M | 19.47%-110.06M | -26.29%-136.67M |
Net business purchase and sale | --0 | ---183.3M | --0 | 101.28%8.76M | -23.89%-684.12M | ---552.2M | ---- | --699.01M | ---- | 101.89%4.03M |
Net investment product transactions | -71.12%-5.07B | -284.00%-2.96B | 381.43%1.61B | -146.80%-571.8M | 75.29%-231.68M | -147.76%-937.58M | 148.75%1.96B | -6,854.91%-4.03B | -85.11%59.62M | -89.48%400.42M |
Net changes in other investments | -182.72%-5.19M | -83.80%6.28M | 468.52%38.75M | 168.16%6.82M | -1.14%-10M | -90.76%-9.89M | -2,140.55%-5.18M | -99.03%254K | 17,431.54%26.12M | 100.63%149K |
Investing cash flow | -58.22%-5.49B | -362.11%-3.47B | 213.49%1.32B | 24.63%-1.17B | 23.12%-1.55B | -225.59%-2.01B | 144.82%1.6B | -6,246.89%-3.58B | -124.19%-56.38M | -93.23%233.04M |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---- | -200.00%-2B | --2B | ---- | ---- | ---- | ---- | ---- |
Net common stock issuance | --0 | --23K | --0 | --2.94B | ---- | -41.28%119.51M | 6,829.08%203.51M | -93.79%2.94M | 118.90%47.26M | ---249.99M |
Increase or decrease of lease financing | 21.43%-53.95M | -13.59%-68.66M | -19.99%-60.45M | ---50.37M | ---- | ---- | ---- | 48.47%-353K | -4.26%-685K | -4.29%-657K |
Cash dividends paid | -23.19%-1.91B | -4.55%-1.55B | -15.16%-1.48B | -6.84%-1.28B | 16.74%-1.2B | -108.17%-1.44B | -16.87%-693.85M | -26.74%-593.71M | -35.78%-468.45M | -25.33%-345.01M |
Net other fund-raising expenses | 30.77%-189.46M | 55.07%-273.67M | -20,398.37%-609.15M | 0.07%3M | --3M | ---- | ---1K | ---- | -100.01%-1K | 898,700.00%8.99M |
Financing cash flow | -13.75%-2.15B | 12.10%-1.89B | -449.25%-2.15B | -148.88%-391.3M | 160.42%800.46M | -170.19%-1.32B | 17.05%-490.35M | -40.12%-591.13M | 28.09%-421.88M | -112.62%-586.67M |
Net cash flow | ||||||||||
Beginning cash position | -51.99%2.49B | 5.54%5.18B | 12.25%4.9B | 5.35%4.37B | -34.68%4.15B | 48.26%6.35B | -40.67%4.28B | 9.65%7.22B | 9.69%6.58B | 203.19%6B |
Current changes in cash | 140.71%1.12B | -1,007.22%-2.75B | -44.51%303.37M | 137.01%546.67M | 110.48%230.65M | -206.50%-2.2B | 170.43%2.07B | -562.65%-2.93B | 8.93%634.35M | -85.48%582.33M |
Effect of exchange rate changes | -47.22%32.11M | 293.63%60.83M | -176.84%-31.42M | -29.40%-11.35M | -1,294.28%-8.77M | -3,410.53%-629K | 102.37%19K | -178.02%-802K | 243.98%1.03M | -105.98%-714K |
Cash adjustments other than cash changes | 0.00%1K | 200.00%1K | ---1K | ---- | ---- | -150.00%-1K | 200.00%2K | ---2K | ---- | -75.00%1K |
End cash Position | 46.37%3.64B | -51.99%2.49B | 5.54%5.18B | 12.25%4.9B | 5.35%4.37B | -34.68%4.15B | 48.26%6.35B | -40.67%4.28B | 9.65%7.22B | 9.69%6.58B |
Free cash flow | 266.67%8.34B | 182.73%2.27B | -46.15%804.63M | 319.73%1.49B | -42.89%355.99M | 4.03%623.35M | -39.11%599.22M | 1.40%984.1M | 26.96%970.49M | 6.99%764.4M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |